REFERENCES
- U.S. Department of Health and Human Services, Public Health Service. Healthy People 2000: National health promotion and disease prevention objectives, 1991, p. 71
- Rath, Matthias. Eradicating Heart Disease. 1993, Health Now, San Francisco, CA
- Harrison, Tinsley R. Principles of Internal Medicine. 1994, 13th edition, McGraw-Hill, pp. 1106-15 and pp. 2434-35
- Johnson, Jeffrey A. and Bootman, J. Lyle. Drug-related morbidity and mortality. Archives of Internal Medicine, Vol. 155, October 9, 1995, pp. 1949-56
- Cheitlin, Melvin D., et al. Clinical Cardiology. 1993, 6th edition, Appleton & Lange, Norwalk, CT
- Vingerling, Johannes R., et al. Age-related macular degeneration is associated with atherosclerosis. American Journal of Epidemiology, Vol. 142, No. 4, August 15, 1995, pp. 404-09
- Goldberg, Burton. Alternative Medicine: The Definitive Guide. 1993, Future Medicine Publishing, Puyallup, WA, pp. 711-22
- Stampfer, Meir J., et al. Vitamin E consumption and the risk of coronary disease in women. The New England Journal of Medicine, Vol. 328, No. 20, May 20, 1993, pp. 1444-49
- Stadtman, Earl R. Protein oxidation and aging. Science, Vol. 257, August 28, 1992, pp. 1220-24
- Cooper, Kenneth H. Antioxidant Revolution. 1994, Thomas Nelson Publishers, pp. 3-28 and pp. 173-87
- Halliwell, Barry. Free radicals and antioxidants: a personal view. Nutrition Reviews, Vol. 52, No. 8, August 1994, pp. 253-65
- Halliwell, Barry. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? The Lancet, Vol. 344, September 10, 1994, pp. 721-24
- Rath, M. and Pauling, L. Solution to the puzzle of human cardiovascular disease: its primary cause is ascorbate deficiency leading to the deposition of lipoprotein(a) and fibrinogen/fibrin in the vascular wall. Journal of Orthomolecular Medicine, 6 (1991), pp. 125-34
- Rath, M. and Pauling, L. Hypothesis: lipoprotein(a) is a surrogate for ascorbate. Proceedings of the National Academy of Sciences of the USA, Vol. 87, No. 16, August 1990, pp. 6204-07
- Diplock, Anthony T. Antioxidant nutrients and disease prevention: an overview. American Journal of Clinical Nutrition, Vol. 53, 1991, pp. 189S-93S
- Street, Debra A., et al. Serum antioxidants and myocardial infarction. Circulation, Vol. 90, No. 3, September 1994, pp. 1154-61
- Morris, Dexter L., et al. Serum carotenoids and coronary heart disease. Journal of the American Medical Association, Vol. 272, No. 18, November 9, 1994, pp. 1439-41
- Meydani, Mohsen. Vitamin E. The Lancet, Vol. 345, January 21, 1995, pp. 170-75
- Khaw, Kay-Tee and Woodhouse, Peter. Interrelation of vitamin C, infection, haemostatic factors, and cardiovascular disease. British Medical Journal, Vol. 310, June 17, 1995, pp. 1559-63
- Gale, Catherine, et al. Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. British Medical Journal, Vol. 310, June 17, 1995, pp. 1563-66
- Woodhouse, P.R. and Khaw, Kay-Tee. Seasonal variations in vitamin C status, infection, fibrinogen and cardiovascular disease - Are they linked? Age and Ageing, Vol. 23, Supplement No. 2, 1994, pp. P5
- Rimm, Eric B., et al. Vitamin E consumption and the risk of coronary heart disease in men. The New England Journal of Medicine, Vol. 328, No. 20, May 20, 1993, pp. 1450-56
- Kardinaal, A.F.M., et al. Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC study. The Lancet, Vol. 342, December 4, 1993, pp. 1379-84
- Ornish, Dean. Program for Reversing Heart Disease. 1991, Ballantine Books, pp. 55-80
- Whitaker, Julian M. Reversing Heart Disease. 1985, Warner Books, NY, pp. 3-14
- Victoria Declaration on Heart Health: Conference report. Canadian Medical Association Journal, Vol. 147, No. 12, December 15, 1992, pp. 1794-95
- Kawachi, Ichiro, et al. Symptoms of anxiety and risk of coronary heart disease. Circulation, Vol. 90, No. 5, November 1994, pp. 2225-29
- Willich, Stefan N., et al. Weekly variation of acute myocardial infarction. Circulation, Vol. 90, No. 1, July 1994, pp. 87-93
- Hoffer, A. Schizophrenia: an evolutionary defence against severe stress. Journal of Orthomolecular Medicine, Vol. 9, No. 4, Fourth Quarter 1994, pp. 205-21
- Fuhrman, Bianca, et al. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. American Journal of Clinical Nutrition, Vol. 61, No. 3, March 1995, pp. 549-54
- Renaud, S. and de Lorgeril, M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. The Lancet, Vol. 339, June 20, 1992, pp. 1523-26
- Frankel, E.N., et al. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. The Lancet, Vol. 341, February 20, 1993, pp. 454-57
- Shaper, A.G., et al. Alcohol and mortality in British men: explaining the U-shaped curve. The Lancet, No. 8623, December 3, 1988, pp. 1267-73
- Salonen, Jukka T., et al. High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men. Circulation, Vol. 86, No. 3, September 1992, pp. 803-11 and 1036-37
- Magnusson, Magnus K, et al. Low iron-binding capacity as a risk factor for myocardial infarction. Circulation, Vol. 89, No. 1, January 1994, pp. 102-08
- Ascherio, Alberto, et al. Dietary iron intake and risk of coronary disease among men. Circulation, Vol. 89, No. 3, March 1994, pp. 969-74
- Bothwell, Thomas H. Overview and mechanisms of iron regulation. Nutrition Reviews, Vol. 53, No. 9, September 1995, pp. 237-45
- Klag, Michael J., et al. Serum cholesterol in young men and subsequent cardiovascular disease. The New England Journal of Medicine, Vol. 328, No. 5, February 4, 1993, pp. 313-17
- Bass, Katherine Miller, et al. Plasma lipoprotein levels as predictors of cardiovascular death in women. Archives of Internal Medicine, Vol. 153, October 11, 1993, pp. 2209-16
- Stensvold, Inger, et al. Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women. British Medical Journal, Vol. 307, November 20, 1993, pp. 1318-22
- Stampfer, Meir J. and Malinow, M. Rene. Can lowering homocysteine levels reduce cardiovascular risk? The New England Journal of Medicine, Vol. 332, No. 5, February 2, 1995, pp. 328-29
- Boushey, Carol J., et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Journal of the American Medical Association, Vol. 274, No. 13, October 4, 1995, pp: 1049-57
- Nygard, Ottar, et al. Total plasma homocysteine and cardiovascular risk profile. Journal of the American Medical Association, Vol. 274, No. 19, November 15, 1995, pp. 1526-33
- Perry, I.J., et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. The Lancet, Vol. 346, November 25, 1995, pp. 1395-98
- Salonen, Jukka T, et al. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in Eastern Finnish men. Circulation, Vol. 91, No. 3, February 1, 1995, pp. 645-55
- Patel, P., et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. British Medical Journal, Vol. 311, September 16, 1995, pp. 711-14
- Davis, Goode P. The Heart: The Living Pump. 1984, Torstar Books, NY, pp. 73-94
- McGinnis, J. Michael and Nestle, Marion. The Surgeon General's report on nutrition and health: policy implications and implementation strategies. American Journal of Clinical Nutrition, Vol. 49, No. 1, January 1989, pp. 23-8
- Barnard, Neal D., et al. The medical costs attributable to meat consumption. Preventive Medicine, Vol. 24, No. 6, November 1995, pp. 646-55
- Frentzel-Beyme, Rainer and Chang-Claude, Jenny. Vegetarian diets and colon cancer: the German experience. American Journal of Clinical Nutrition, Vol. 59, May 1994, pp. 1143S-52S
- Troisi, Rebecca, et al. Trans-fatty acid intake in relation to serum lipid concentrations in adult men. American Journal of Clinical Nutrition, Vol. 56, December 1992, pp. 1019-24
- Kromhout, Daan, et al. Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the seven countries study. Preventive Medicine, Vol. 24, No. 3, May 1995, pp. 308-15
- Ascherio, Alberto, et al. Trans-fatty acids intake and risk of myocardial infarction. Circulation, Vol. 89, No. 1, January 1994, pp. 94-101
- Willett, Walter C., et al. Intake of trans fatty acids and risk of coronary heart disease among women. The Lancet, Vol. 341, March 6, 1993, pp. 581-85
- Diehl, Hans. To Your Health. 1987, The Quiet Hour, Redlands, CA, pp. 41-53
- WHO and FAO joint consultation: fats and oils in human nutrition. Nutrition Reviews, Vol. 53, No. 7, July 1995, pp. 202-05
- Seidelin, Kaj N., et al. n-3 fatty acids in adipose tissue and coronary artery disease are inversely related. American Journal of Clinical Nutrition, Vol. 55, June 1992, pp. 1117-19
- Kromhout, Daan, et al. The protective effect of a small amount of fish on coronary heart disease mortality in an elderly population. International Journal of Epidemiology, Vol. 24, No. 2, April 1995, pp. 340-45
- Agren, J.J., et al. Boreal freshwater fish diet modifies the plasma lipids and prostanoids and membrane fatty acids in man. LIPIDS, Vol. 23, No.10, October 1988, pp. 924-29
- Nordoy, Arne. Is there a rational use for n-3 fatty acids (fish oils) in clinical medicine? Drugs, Vol. 42, No. 3, 1991, pp. 331-42
- Law, M.R., et al. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? British Medical Journal, Vol. 308, February 5, 1994, pp. 367-72
- Allred, John B. Lowering serum cholesterol: who benefits? Journal of Nutrition, Vol. 123, August 1993, pp. 1453-59
- Sacks, Frank M., et al. Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients. The Lancet, Vol. 344, October 29, 1994, pp. 1182-86
- Ravnskov, U. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. British Medical Journal, Vol. 305, July 4, 1992, pp. 15-19
- Haq, I.U., et al. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease. The Lancet, Vol. 346, December 2, 1995, pp. 1467-71
- Hoeg, Jeffrey M. New guidelines for the evaluation and treatment of hypercholesterolemia. Modern Medicine, Vol. 56, No. 12, December 1988, pp. 106-112
- Feldman, Elaine B. and Kuske, Terrance T. Lipid disorders: Diet and drug therapy. Modern Medicine, Vol. 56, No. 9, September 1988, pp. 60-71
- Denke, Margo A. and Grundy, Scott M. Individual responses to a cholesterol-lowering diet in 50 men with moderate hypercholesterolemia. Archives of Internal Medicine, Vol. 154, February 14, 1994, pp. 317-25
- Steinmetz, Kristi A., et al. Effect of consumption of whole milk and skim milk on blood lipid profiles in healthy men. American Journal of Clinical Nutrition, Vol. 59, March 1994, pp. 612-18
- Hegsted, D. Mark, et al. Dietary fat and serum lipids: an evaluation of the experimental data. American Journal of Clinical Nutrition, Vol. 57, June, 1993, pp. 875-83
- Cara, Louis, et al. Long-term wheat germ intake beneficially affects plasma lipids and lipoproteins in hypercholesterolemic human subjects. Journal of Nutrition, Vol. 122, February 1992, pp. 317-26
- Kashtan, Hanoch, et al. Wheat-bran and oat-bran supplements' effects on blood lipids and lipoproteins. American Journal of Clinical Nutrition, Vol. 55, May 1992, pp. 976-80
- Anderson, James W., et al. Meta-analysis of the effects of soy protein intake on serum lipids. The New England Journal of Medicine, Vol. 333, No. 5, August 3, 1995, pp. 276-82
- Erdman, John W. Control of serum lipids with soy protein. The New England Journal of Medicine, Vol. 333, No. 5, August 3, 1995, pp. 313-15
- Potter, Susan M., et al. Depression of plasma cholesterol in men by consumption of baked products containing soy protein. American Journal of Clinical Nutrition, Vol. 58, No. 3, September 1993, pp. 501-06
- Denke, Margo A., et al. Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men. Journal of Nutrition, Vol. 123, June 1993, pp. 1047-53
- Imai, K. and Nakachi, K. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. British Medical Journal, Vol. 310, March 18, 1995, pp. 693-96
- Hertog, Michael G.L., et al. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. The Lancet, Vol. 342, October 23, 1993, pp. 1007-11
- Fraser, Gary E., et al. A possible protective effect of nut consumption on risk of coronary heart disease. Archives of Internal Medicine, Vol. 152, July 1992, pp. 1416-24
- Phelps, Stacy and Harris, William S. Garlic supplementation and lipoprotein oxidation susceptibility. Lipids, Vol. 28, No. 5, May 1993, pp. 475-77
- Mantzioris, Evangeline, et al. Dietary substitution with an alpha-linolenic acid-rich vegetable oil increases eicosapentaenoic acid concentrations in tissues. American Journal of Clinical Nutrition, Vol. 59, June 1994, pp. 1304-9
- Howard, Nigel. Renaud and the mystery of the Cretan diet. ELAN - The European, June 24-30, 1994, p. 20
- Simon, Joel A., et al. Serum fatty acids and the risk of coronary heart disease. American Journal of Epidemiology, Vol. 142, No. 5, September 1, 1995, pp. 469-76
- Kamido, Hiroshi, et al. Lipid composition of platelets from patients with atherosclerosis: Effect of purified eicosapentaenoic acid ethyl ester administration. LIPIDS, Vol. 23, No. 10, October 1988, pp. 917-23
- Smith, George Davey and Pekkanen, Juha. Should there be a moratorium on the use of cholesterol lowering drugs? British Medical Journal, Vol. 304, February 15, 1992, pp. 431-3
- Hulley, Stephen B., et al. Health policy on blood cholesterol. Circulation, Vol. 86, No. 3, September 1992, pp. 1026-29 and 1046-60
- Hoffer, Abram. Orthomolecular Medicine for Physicians. 1989, Keats Publishing, New Canaan, CT, pp. 115-26
- Keenan, Joseph M., et al. Treatment of hypercholesterolemia: comparison of younger versus older patients using wax-matrix sustained-release niacin. Journal of the American Geriatrics Society, Vol. 40, No. 1, January 1992, pp. 12-18
- McKenney, James M., et al. A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients. Journal of the American Medical Association, Vol. 271, No. 9, March 2, 1994, pp. 672-77
- King, James M., et al. Evaluation of effects of unmodified niacin on fasting and postprandial plasma lipids in normolipidemic men with hypoalphalipoproteinemia. The American Journal of Medicine, Vol. 97, October 1994, pp. 323-31
- Peto, Richard, et al. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. The Lancet, Vol. 339, May 23, 1992, pp. 1268-78
- Barry, Joan, et al. Effect of smoking on the activity of ischemic heart disease. Journal of the American Medical Association, Vol. 261, No. 3, January 20, 1989, pp. 398-402
- Kritz, Harald, et al. Passive smoking and cardiovascular risk. Archives of Internal Medicine, Vol. 155, October 9, 1995, pp. 1942-48
- Kawachi, Ichiro, et al. Smoking cessation and decreased risk of stroke in women. Journal of the American Medical Association, Vol. 269, No. 2, January 13, 1993, pp. 232-36
- Abbey, Mavis, et al. Antioxidant vitamins and low-density-lipoprotein oxidation. American Journal of Clinical Nutrition, Vol. 58, No. 3, September 1993, pp. 525-32
- Voelker, Rebecca. Recommendations for antioxidants: how much evidence is enough? Journal of the American Medical Association, Vol. 271, No. 15, April 20, 1994, pp. 1148-49
- Hoffman, Richard M and Garewal, Harinder S. Antioxidants and the prevention of coronary heart disease. Archives of Internal Medicine, Vol. 155, February 13, 1995, pp. 241-46
- Sies, Helmut and Stahl, Wilhelm. Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. American Journal of Clinical Nutrition, Vol. 62 (suppl), December 1995, pp. 1315S-21S
- Jha, Prabhat, et al. The antioxidant vitamins and cardiovascular disease. Annals of Internal Medicine, Vol. 123, No. 11, December 1, 1995, pp. 860-72
- Chalmers, Thomas C. Antioxidants and cardiovascular disease: why do we still not have the answers? Annals of Internal Medicine, Vol. 123, No. 11, December 1, 1995, p. 887
- Frei, Balz. Reactive oxygen species and antioxidant vitamins: mechanisms of action. American Journal of Medicine, Vol. 97, Suppl. 3A, September 26, 1994, pp. 5S-13S
- Pandey, Dilip K., et al. Dietary vitamin C and beta-carotene and risk of death in middle-aged men. American Journal of Epidemiology, Vol. 142, No. 12, December 15, 1995, pp. 1269-78
- Khaw, Kay-Tee and Woodhouse, Peter. Interrelation of vitamin C, infection, haemostatic factors, and cardiovascular disease. British Medical Journal, Vol. 310, June 17, 1995, pp. 1559-63
- Gale, Catherine R., et al. Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. British Medical Journal, Vol. 310, June 17, 1995, pp. 1563-66
- Woodhouse, P.R. and Khaw, Kay-Tee. Seasonal variations in vitamin C status, infection, fibrinogen and cardiovascular disease - are they linked? Age and Ageing, Vol. 23, Supplement No. 2, 1994, p. P5
- Johnston, Carol S., et al. Vitamin C elevates red blood cell glutathione in healthy adults. American Journal of Clinical Nutrition, Vol. 58, August 1993, pp. 103-05
- Moran, John P., et al. Plasma ascorbic acid concentrations relate inversely to blood pressure in human subjects. American Journal of Clinical Nutrition, Vol. 57, March 1993, pp. 213-17
- Diplock, Anthony T. Safety of antioxidant vitamins and beta-carotene. American Journal of Clinical Nutrition, Vol. 62 (suppl), 1995, pp. 1510S-16S
- Halliwell, Barry. Oxidation of low-density lipoproteins: questions of initiation, propagation, and the effect of antioxidants. American Journal of Clinical Nutrition, Vol. 61, No. 3, March 1995, pp. 670S-77S
- Packer, L. Protective role of vitamin E in biological systems. American Journal of Clinical Nutrition, Vol. 53, 1991, pp. 1050S-55S
- Steinberg, Daniel, et al. Beyond cholesterol. The New England Journal of Medicine, Vol. 320, 1989, pp. 915-24
- Sevanian, Alex and McLeod, L.L. Cholesterol auto-oxidation in phospholipid membrane bilayers. Lipids, Vol. 22, 1987, pp. 627-36
- Hoffman, Richard M. and Garewal, Harinder S. Antioxidants and the prevention of coronary heart disease. Archives of Internal Medicine, Vol. 155, February 13, 1995, pp. 241-46
- Halliwell, Barry. Oxidation of low-density lipoproteins: questions of initiation, propagation, and the effect of antioxidants. American Journal of Clinical Nutrition, Vol. 61, No. 3, March 1995, pp. 670S-77S
- Jialal, Ishwarlal and Grundy, Scott M. Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein. Journal of Lipid Research, Vol. 33, June 1992, pp. 899-906
- Stampfer, Meir J. and Rimm, Eric B. Epidemiologic evidence for vitamin E in prevention of cardiovascular disease. American Journal of Clinical Nutrition, Vol. 62 (suppl), 1995, pp. 1365S-69S
- Salonen, Jukka T., et al. Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow up study in men. British Medical Journal, Vol. 311, October 28, 1995, pp. 1124-27
- Bendich, A. and Machlin, L.J. Safety of oral intake of vitamin E. American Journal of Clinical Nutrition, Vol. 48, 1988, pp. 612-19
- Meydani, S.N., et al. Assessment of the safety of high-dose, short-term supplementation with vitamin E in healthy older adults. American Journal of Clinical Nutrition, Vol. 60, November 1994, pp. 704-09
- Allard, Johane P. Effects of beta-carotene supplementation on lipid peroxidation in humans. American Journal of Clinical Nutrition, Vol. 59, April 1994, pp. 884-90
- Goyer, Robert A. Nutrition and metal toxicity. American Journal of Clinical Nutrition, Vol. 61, No. 3, March 1995, pp. 646S-650S
- Salonen, J.T., et al. Interactions of serum copper, selenium and low density lipoprotein cholesterol in atherogenesis. British Medical Journal, Vol. 302, No. 6779, March 1991, pp. 756-60
- Oldfield, J.E. Some implications of selenium for human health. Nutrition Today, July/August 1991, pp. 6-11
- Frei, Balz, et al. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc. Natl. Acad. Sci. USA, Medical Sciences, Vol. 87, June 1990, pp. 4879-83
- Stocker, Roland, et al. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc. Natl. Acad. Sci. USA, Medical Sciences, Vol. 88, March 1991, pp. 1646-50
- Hanaki, Yoshihiro, et al. Ratio of low-density lipoprotein cholesterol to ubiquinone as a coronary risk factor. The New England Journal of Medicine, Vol. 325, No. 11, September 12, 1991, pp. 814-15
- Mohr, D., et al. Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation. Biochimica et Biophysica Acta, Vol. 1126, No. 3, June 26, 1992, pp. 247-54
- Greenberg, Steven and Frishman, William H. Co-enzyme Q10: a new drug for cardiovascular disease. Journal of Clinical Pharmacology, Vol. 30, 1990, pp. 596-608
- Behme, Margaret T. Nicotinamide and diabetes prevention. Nutrition Reviews, Vol. 53, No. 5, May 1995, pp. 137-39
- Eisenberg, Mark J. Magnesium deficiency and sudden death. American Heart Journal, Vol. 124, No. 2, August 1992, pp. 544-49
- Shechter, Michael, et al. The rationale of magnesium supplementation in acute myocardial infarction: a review of the literature. Archives of Internal Medicine, Vol. 152, November 1992, pp. 2189-96
- Ott, Peter and Fenster, Paul. Should magnesium be part of the routine therapy for acute myocardial infarction? American Heart Journal, Vol. 124, No. 4, October 1992, pp. 1113-18
- Dubey, Anjani and Solomon, Richard. Magnesium, myocardial ischaemia and arrhythmias: the role of magnesium in myocardial infarction. Drugs, Vol. 37, 1989, pp. 1-7
- England, Michael R., et al. Magnesium administration and dysrhythmias after cardiac surgery. Journal of the American Medical Association, Vol. 268, No. 17, November 4, 1992, pp. 2395-2402
- Yusuf, Salim, et al. Intravenous magnesium in acute myocardial infarction. Circulation, Vol. 87, No. 6, June 1993, pp. 2043-46
- Woods, Kent L. and Fletcher, Susan. Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). The Lancet, Vol. 343, April 2, 1994, pp. 816-19
- Manz, M., et al. Behandlung von herzrhythmusstorungen mit magnesium. Deutsche Medi Wochenschrifte, Vol. 115, No. 10, March 9, 1990, pp. 386-90
- Iseri, Lloyd T., et al. Magnesium therapy of cardiac arrhythmias in critical-care medicine. Magnesium, Vol. 8, 1989, pp. 299-306
- Appel, Lawrence J., et al. Does supplementation of diet with "fish oil" reduce blood pressure? Archives of Internal Medicine, Vol. 153, June 28, 1993, pp. 1429-38
- Kendler, Barry S. Garlic (Allium sativum) and onion (Allium cepa): a review of their relationship to cardiovascular disease. Preventive Medicine, Vol. 16, 1987, pp. 670-85
- Hertog, Michael G.L., et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Archives of Internal Medicine, Vol. 155, February 27, 1995, pp. 381-86
- Supplemental dietary potassium reduced the need for antihypertensive drug therapy. Nutrition Reviews, Vol. 50, No. 5, May 1992, pp. 144-45
- Ascherio, Alberto, et al. A prospective study of nutritional factors and hypertension among US men. Circulation, Vol. 86, No. 5, November 1992, pp. 1475-84
- Witteman, Jacqueline C.M., et al. Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. American Journal of Clinical Nutrition, Vol. 60, July 1994, pp. 129-35
- Geleijnse, J.M., et al. Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension. British Medical Journal, Vol. 309, August 13, 1994, pp. 436-40
- Reusser, Molly E. and McCarron, David A. Micronutrient effects on blood pressure regulation. Nutrition Reviews, Vol. 52, No. 11, November 1994, pp. 367-75
- Burchfiel, Cecil M., et al. Physical activity and incidence of diabetes: the Honolulu Heart Program. American Journal of Epidemiology, Vol. 141, No. 4, February 15, 1995, pp. 360-68
- Kiely, Dan K., et al. Physical activity and stroke risk: the Framingham Study. American Journal of Epidemiology, Vol. 140, No. 7, October 1, 1994, pp. 608-20
- Shinton, Roger and Sagar, Gian. Lifelong exercise and stroke. British Medical Journal, Vol. 307, July 24, 1993, pp. 231-34
- Czernin, Johannes, et al. Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve. Circulation, Vol. 92, No. 2, July 15, 1995, pp. 197-204
- Spelsberg, Angela and Manson, Joann E. Physical activity in the treatment and prevention of diabetes. Comprehensive Therapy, Vol. 21, No. 10, October 1995, pp. 559-64
- Wannamethee, Goya and Shaper, A.G. Physical activity and stroke in British middle aged men. British Medical Journal, Vol. 304, March 7, 1992, pp. 597-601
- Godlee, Fiona. On your bikes. British Medical Journal, Vol. 304, March 7, 1992, pp. 588-87
- O'Connor, Gerald T., et al. Physical exercise and reduced risk of nonfatal myocardial infarction. American Journal of Epidemiology, Vol. 142, No. 11, December 1, 1995, pp. 1147-56
- Markovitz, Jerome H., et al. Psychological predictors of hypertension in the Framingham Study. Journal of the American Medical Association, Vol. 270, No. 20, November 24, 1993, pp. 2439-43
- BP rise during exercise: a simple predictor of heart attack? Geriatrics, Vol. 48, No. 11, November 1993, p. 26
- Graboys, Thomas B. Results of a second-opinion trial among patients recommended for coronary angiography. Journal of the American Medical Association, Vol. 268, No. 18, November 11, 1992, pp. 2537-40
- Chick, Thomas W., et al. The effect of antihypertensive medications on exercise performance: a review. Medicine and Science in Sports and Exercise, Vol. 20, No. 5, October 1988, pp. 447-52
- A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor aschemic stroke. The New England Journal of Medicine, Vol. 325, No. 18, October 31, 1991, pp. 1261-66
- Warren, Joan L., et al. Hospitalizations with adverse events caused by digitalis therapy among elderly Medicare beneficiaries. Archives of Internal Medicine, Vol. 154, July 11, 1994, pp. 1482-87
- Avanzini, Fausto, et al. Antiarrhythmic drug prescription in patients after myocardial infarction in the last decade. Archives of Internal Medicine, Vol. 155, May 22, 1995, pp. 1041-45
- Gapinski, James P., et al. Preventing restenosis with fish oils following coronary angioplasty. Archives of Internal Medicine, Vol. 153, July 12, 1993, pp. 1595-1601
- Haeger, K. Long-term treatment of intermittent claudication with vitamin E. American Journal of Clinical Nutrition, Vol. 27, 1974, pp. 1179-81
- Livingstone, P.D. and Jones, C. Treatment of intermittent claudication with vitamin E. The Lancet, Vol. 2, 1958, pp. 602-04
- Williams, H.T.G., et al. Alpha tocopherol in the treatment of intermittent claudication. Surg. Gynecol. Obstet., Vol. 132, 1971, pp. 662-66
- Hodis, Howard N., et al. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. Journal of the American Medical Association, Vol. 273, No. 23, June 21, 1995, pp. 1849-54
- Kamikawa, T., et al. Effects of coenzyme Q10 on exercise tolerance in chronic stable angina pectoris. American Journal of Cardiology, Vol. 56, 1985, p. 247
- Mortensen, S.A., et al. Long-term coenzyme Q10 therapy: a major advance in the management of resistant myocardial failure. Drug Exp. Clin. Res. (8), 1985, p. 581
- Langsjoen, P.H., et al. Effective treatment with coenzyme Q10 of patients with chronic myocardial disease. Drug Exp. Clin. Res. (8), 1985, p. 577
- Langsjoen, P.H., et al. Response of patients in classes III and IV of cardiomyopathy to therpay in a blind and crossover trial with coenzyme Q10. Proc. Natl. Acad. Sci. USA, Vol. 82, 1985, p. 4240
- Yamagami, T., et al. Effect of coenzyme Q10 on essential hypertension: a double-blind controlled study, in Folkers, K. and Yamamura, Y. (eds): Biomedical and Clinical Aspects of Coenzyme Q, Vol. 5, Elsevier Sci. Publ. B.V., Amsterdam, 1986, pp. 337-43
- Tanaka, J., et al. Coenzyme Q10: the prophylactic effect on low cardiac output following cardiac valve replacement. Ann. Thorac. Surg. Vol. 33, No. 2, 1982, p. 145
- Sunamori, M., et al. Clinical application of coenzyme Q to coronary artery bypass graft surgery, in Folkers, K. and Yamamura, Y. (eds): Biomedical and Clinical Aspects of Coenzyme Q, Vol. 4, Elsevier Sci. Publ. B.V., Amsterdam, 1984, pp. 333-42
- Oda, T., et al. Stress echocardiography for pediatric patients with symptomatic mitral valve prolapse. Jpn. Circ. J. Vol. 47, 1983, p. 1335
- Oda, T. and Hamamoto, K. Effect of coenzyme Q10 on the stress-induced decrease in cardiac performance in pediatric patients with mitral valve prolapse. Jpn. Circ. J. Vol. 48, 1984, p. 1387
- Oda, T. Coenzyme Q10 therapy on the cardiac dysfunction in patients with mitral valve prolapse - dose vs. effect and dose vs. serum level of coenzyme Q10, in Folkers, K. and Yamamura, Y. (eds): Biomedical and Clinical Aspects of Coenzyme Q, Vol. 5, Elsevier Sci. Publ. B.V., Amsterdam, 1986, pp. 269-80
- Sueta, Carla A., et al. Effect of acute magnesium administration on the frequency of ventricular arrhythmia in patients with heart failure. Circulation, Vol. 89, No. 2, February 1994, pp. 660-66
- Siscovick, David S., et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and risk of primary cardiac arrest. Journal of the American Medical Association, Vol. 274, No. 17, November 1, 1995, pp. 1363-67
- Shimon, I., et al. Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. American Journal of Medicine, Vol. 98, May 1995, pp. 485-90
- Kleijnen, Jos and Knipschild, Paul. Ginkgo biloba. The Lancet, Vol. 340, November 7, 1992, pp. 1136-39
- Ammon, H.P.T. and Handel, M. Crataegus, toxicology and pharmacology, Pt. 1: Toxicity. Planta Medica - Journal of Medicinal Plant Research, Vol. 43, No. 2, October 1981, pp. 105-20 (in German)
- Ammon, H.P.T. and Handel, M. Crataegus, toxicology and pharmacology, Pt 2: Pharmacodynamics. Planta Medica - Journal of Medicinal Plant Research, Vol. 43, No. 3, November 1981, pp. 209-39 (in German)
- O'Conolly, Von M., et al. Behandlung der nachlassenden herzleistung. Fortschr. Med., Vol. 104, No. 42, November 13, 1986, pp. 805-08
- Worcester, Marian C., et al. Early programmes of high and low intensity exercise and quality of life after acute myocardial infarction. British Medical Journal, Vol. 307, November 13, 1993, pp. 1244-47
- Wang, Jong-shyan, et al. Different effects of strenuous exercise and moderate exercise on platelet function in men. Circulation, Vol. 90, No. 6, December 1994, pp. 2877-85
- Goldberg, Burton. Alternative Medicine: The Definitive Guide. 1993, Future Medicine Publishing, Puyallup, WA, pp. 126-33
- Chappell, L. Terry and Stahl, John P. The correlation between EDTA chelation therapy and improvement in cardiovascular function: a meta-analysis. Journal of Advancement in Medicine, Vol. 6, No. 3, Fall 1993, pp. 139-60
- Hancke, C. and Flytlie, K. Benefits of EDTA chelation therapy in arteriosclerosis: a retrospective study of 470 patients. Journal of Advancement in Medicine, Vol. 6, No. 3, Fall 1993, pp. 161-71
This article was first published in International Health News in February - April 1996
|